Skip to main content
. 2020 Apr 23;10:548. doi: 10.3389/fonc.2020.00548

Figure 1.

Figure 1

(A) Current universal HPV vaccination to all populations without considering molecular genetic variations. *The antibody levels plateau and a significant waning within a certain time-frame in (A), is proposed to occur only in a small number of women in the vaccinated population. (B) Proposed individualized HPV vaccination according to specific population immunogenetic and immunogenomic profiling.